Product: A nonpyrogenic, sterile 5% Sodium Bicarbonate Injection, USP.
Composition and Usage: Composed of Sodium Bicarbonate and Water for injection. This product is administered intravenously under medical supervision, primarily for correction of metabolic acidosis in cardiac arrest situations.
Precautions: Prior and ongoing arterial blood gas analyses are prescribed to prevent risk of overdosage. Monitoring electrolyte levels, particularly potassium, is required during treatment.
Side Effects: Potential side effects include alkalosis, hypokalemia, fluid or sodium overload and hypernatremia.
Storage: Safely store below 25°C and away from light.
The Sodium Bicarbonate Injection is a sterile, nonpyrogenic 5% solution engineered for intravenous administration. Its primary function is to combat metabolic acidosis linked with cardiac arrest. The product is injection-grade and available globally.
Known for its efficacy in countering metabolic acidosis, especially during cardiac arrest situations, it aids to restore the body's pH balance and improves patient prognosis. Acidic conditions in the blood can lead to detrimental health effects; the Sodium Bicarbonate Injection effectively neutralizes these conditions.
Prudent utilization must be exercised to prevent overdosage. It is highly recommended that patients undergo arterial blood gas analyses before welcoming this treatment and also during the treatment course.
The use of this injection amid pregnant or lactating women is a topic that demands careful risk assessment. Therefore, consultation with a healthcare professional is imperative.
Prolonged use or over-correction may contribute to alkalosis and/or hypokalaemia. Users should follow the recommended dosage to minimize these risks.
Store the Sodium Bicarbonate Injection in a controlled environment, maintaining a temperature below 25°C.